- Home
- ARMP vs FNGR Comparison
ARMP vs FNGR Comparison
Compare ARMP & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- FNGR
- Stock Information
- Founded
- ARMP N/A
- FNGR 2016
- Country
- ARMP United States
- FNGR Singapore
- Employees
- ARMP N/A
- FNGR N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- FNGR Computer Software: Prepackaged Software
- Sector
- ARMP Health Care
- FNGR Technology
- Exchange
- ARMP Nasdaq
- FNGR Nasdaq
- Market Cap
- ARMP 80.0M
- FNGR 74.3M
- IPO Year
- ARMP N/A
- FNGR N/A
- Fundamental
- Price
- ARMP $2.11
- FNGR $1.37
- Analyst Decision
- ARMP Strong Buy
- FNGR
- Analyst Count
- ARMP 1
- FNGR 0
- Target Price
- ARMP $7.00
- FNGR N/A
- AVG Volume (30 Days)
- ARMP 8.2K
- FNGR 255.3K
- Earning Date
- ARMP 03-20-2025
- FNGR 01-14-2025
- Dividend Yield
- ARMP N/A
- FNGR N/A
- EPS Growth
- ARMP N/A
- FNGR N/A
- EPS
- ARMP N/A
- FNGR N/A
- Revenue
- ARMP $5,467,000.00
- FNGR $33,570,107.00
- Revenue This Year
- ARMP $23.87
- FNGR $260.03
- Revenue Next Year
- ARMP N/A
- FNGR N/A
- P/E Ratio
- ARMP N/A
- FNGR N/A
- Revenue Growth
- ARMP 34.92
- FNGR N/A
- 52 Week Low
- ARMP $1.80
- FNGR $1.03
- 52 Week High
- ARMP $4.48
- FNGR $3.96
- Technical
- Relative Strength Index (RSI)
- ARMP 56.44
- FNGR 57.63
- Support Level
- ARMP $1.85
- FNGR $1.12
- Resistance Level
- ARMP $2.08
- FNGR $1.38
- Average True Range (ATR)
- ARMP 0.12
- FNGR 0.09
- MACD
- ARMP 0.00
- FNGR 0.02
- Stochastic Oscillator
- ARMP 56.67
- FNGR 92.59
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.